Effect of Extracorporeal Shockwave Therapy on Pruritus in Neurodermatitis Patients

N/ACompletedNCT07206680

Cairo University34 enrolled

Overview

The purpose of this study is to evaluate the therapeutic effect of shockwave therapy on reducing pruritus in neurodermatitis patients.

Based on the occurrence of side effects caused by conventional medication for prolonged employment, dermatologists and patients show solicitude for multifaceted effective methods to control the chronic and relapsing nature of neurodermatitis. Although new modalities are continuously coming up for pruritus, there remains a great gap for providing symptom relief. Furthermore, there is a lack in the quantitative knowledge and information in the published studies about benefits of shockwave therapy on the treatment of pruritus in neurodermatitis patients. So, this study is designed to outline the therapeutic efficacy of shockwave therapy on the treatment of pruritus in neurodermatitis patients.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Neurodermatitis

Interventions

Shockwave therapyDEVICE

The procedures for Extracorporeal Shockwave Therapy (ESWT) involve several steps. First, the patient is positioned comfortably, and the physiotherapist explains the treatment procedure. Before the session begins, the device cables are checked for proper functioning. The shockwave type used is Non-Focused/Radial, with a treatment duration not exceeding 10 minutes. The frequency is set at 4 Hz, and the intensity ranges from 0.05 to 0.20 mJ/mm². Each session involves a total of 1000 to 2000 shocks. The treatment consists of four sessions, each held once a week.

Emollients & corticosteroidsDRUG

Patients in both groups will receive emollients \& corticosteroids for one month.

Eligibility

Sex: ALLMin age: 55 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age range between 55:75 years. * Male and female patients will participate in the study. * All patients have neurodermatitis. * All patients will be received the same approach of medication and nursing care. * All patients enrolled in the study will have their informed consent. Exclusion Criteria: * Patients diagnosed with cancer. * Pregnant woman. * active infection. * Patients with any systemic diseases that may interfere with the objectives of the study. * Cardiac pacemakers or other implantable devices. * Current anticoagulation use. * Any other cause of itching

Locations (1)

Suez Canal University Hospital

Ismailia, Egypt

Outcomes

Primary Outcomes

5-D Itching Scale

The 5-D Itching Scale will be used to assess the improvement of cases by evaluating pruritus severity. Patients will complete the scale both before starting the treatment and at four sessions following the treatment. The following steps will be followed during the assessment: the patient will be positioned comfortably (sitting position), the physiotherapist will explain the pruritus symptoms score to the patient, and the patient will determine their points on the 5-D itch scale.

Time frame: one month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.